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Ms Body Mass Index Really the Best
easure of Obesity in Individuals?
n the August 19, 2008, edition of the Journal, Gelber et al. (1)
resent data from the Physician’s and Women’s Health studies and
onclude that, although waist-to-height ratio (WHtR) has the
trongest gradient in the association with incident cardiovascular
isease (CVD), “differences between BMI [body mass index] and
HtR in association with CVD. . .[are] small and likely not
linically consequential.” They suggest that “BMI may remain the
ost clinically practical measure of adiposity.” Litwin (2), in an
ccompanying editorial, makes the general argument that “clinical
racticality is frequently overshadowed by statistical significance”
nd that, in the interests of clarity and to avoid equivocation, BMI
hould be retained as the principal and universal measure of obesity.
A critical point is being missed here, which relates to the
ranslation of measures from large population studies to the
anagement of the individual. In large population studies per-
ormed in adults, BMI provides a useful surrogate index of obesity
ecause it corrects for individuals who are heavy by virtue of the
act that they are also tall. In large population studies, a higher
MI might reasonably be assumed due to excess fat mass. Of
ourse it is accepted that BMI provides no information regarding
he composition of the weight, or its distribution, but this does not
atter so much when the study is performed in 49,000 subjects.
owever, populations are comprised of individuals, and it is
ndividuals we treat. In adults, body height does not change over
ime, so BMI reverts to a measure of gross body weight in the
ndividual. Is it valid to simply measure body weight as an index of
atness when following up patients? If so, why do we measure BMI
n the clinic at all?
Moreover, changes in BMI in the individual cannot be appro-
riately used as an index of change in obesity or cardiovascular risk.
o make the point using a relevant example, exercise is an
ntervention that is widely prescribed for obese subjects. It is also
n intervention that can increase skeletal muscle and lean body
ass. Exercise studies often result in no change in body weight or
MI, whereas sensitive imaging modalities reveal significant de-
reases in fat mass, including abdominal fat mass (3). Exercise has
ountervailing impacts on fat and lean body mass (4), which render
MI meaningless as an index of obesity, adiposity, or risk in
ndividuals.
Consideration of changes in body composition, rather than
easures of body weight, including BMI, remains important, and
his may be one reason to use the WHtR index, in preference to
MI, as a simple, uncomplicated measure that moves patients
efficiently through our offices.”
Daniel J. Green
Research Institute for Sport and Exercise Science
iverpool John Moores University a5-21 Webster Street
iverpool Merseyside L3 2ET
nited Kingdom
-mail: d.j.green@ljmu.ac.uk
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roblems in Measurement
f Body “Fatness”
elber et al. (1) make an important contribution in comparing
nthropometric measurements as predictors of cardiovascular dis-
ase (CVD). These authors and an editorialist (2), accept that
fatness” relates to CVD, and point out the controversy regarding
otal fat content versus some “central” fat accumulation in promot-
ng CVD. Both entertain reservations as to whether body mass
ndex (BMI) measures general obesity or whether waist circum-
erence (WC) (or some modification, such as waist-to-hip ratio
WHR] or waist-to-height [WHtR]) measures “central” obesity.
BMI, calculated from body weight and height2, does not
eparate the components of its 2-compartment model: lean body
ass (LBM) and total body fat (WF). Equating elevated BMI
ith “obesity” or “adiposity” incorrectly assumes that LBM is
onstant at any given height so that any BMI change represents a
hange of WF. Gelber et al. (1) and Litwin (2) are aware of this,
ut perhaps not of the resulting magnitude and frequency of
otential error. Using a direct measurement of body fat, within a
omogeneous cohort of similar height, LBM varies at least 20%
rom the group mean, and an individual’s deviation from average
eight at this height can be all WF, all LBM, or any combination
f these (3). For young women of identical height, weight, and
MI, a20% range of LBM is associated with a remarkable range
f fat content (WF/body weight), from 10% to 40% (calculated
rom Lesser et al. [3]).
The interpretation of BMI (and, to a lesser extent, of WHR and
HtR) is further complicated by aging changes within the LBM.
he Gelber et al. (1) subjects were in the fifth to ninth decades.
ost older people lose muscle and bone mass; many also loseppreciable height (4). Such LBM changes vary widely among
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February 10, 2009:526–9ndividuals and defy reasonable adjustment, and BMI use in this
opulation becomes highly questionable.
The “central versus total fat” controversies do not seem firmly
ased, as BMI is not a trustworthy measure of total body fat, and
here is only limited evidence that WC represents some vaguely
efined central “fat compartment.” WC is probably less perturbed
y aging changes, although vertebral compressions can shorten the
runk and “falsely” increase waist measurement. Hip circumference
s affected somewhat by fatness but probably best correlates with
he size of the frame/LBM. Height also correlates with LBM,
ith the noted 20% range of LBM at a given height. Thus, the
atios of WHR and WHtR probably serve as approximate adjust-
ents of WC to individual size. WHtR, an admittedly coarse
easurement, is probably the best available approximation of
verall “fatness,” WF/body weight, for large groups and over broad
anges of age, and was statistically the best model fit (1).
In large populations, almost any reasonable tool, even “eye-
alling,” should provide some approximation of fatness and cor-
elate with fat-related conditions. Behnke (5), who pioneered
uman densitometry, later accommodated to a tape measure and
imple procedures for the practical estimation of body fatness.
ntil improved methods are available, we can best understand
elationships of body composition and future morbidity by appre-
iating the limitations of current anthropometric tools.
Gerson T. Lesser, MD
Jewish Home and Hospital
20 West 106th Street
ew York, New York 10025
-mail: glesser@jhha.org
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eply
he assessment of clinical usefulness for any measure, and perhaps
articularly for measures of adiposity, relies largely on preference
hen the measures are statistically similar in their associations with
elevant outcomes. While it is true that our study’s results (1) are
ased on analyses of large cohorts, we do not agree that they are
imited in their application to individuals, as suggested by Dr.
reen. In our study, we found that measures of obesity other than
ody mass index (BMI) do not substantially improve statistical
rediction of cardiovascular outcomes. At the same time, we
cknowledged the limitations of BMI, both in misclassifying the
uscular lean and in its deficiency in describing the distribution ofody fat. WThe question then shifts to which measure should be employed
linically. Conveying the risks of obesity to patients in daily clinical
ractice requires, in part, a measure substantiated in standard
efinitions of overweight and obese. While, for a given individual,
hanges in BMI over time will rely on changes in body weight, the
eaning of these changes in weight is often interpreted as progress
oward a healthier goal based on BMI. We do not yet understand
ully how best to target modifications of the waist circumference or
aist-height-ratio, since body fat distribution appears less mallea-
le to change than overall weight. Further study on approaches to
nd benefits of altering body composition and waist circumference
ay clarify these issues.
In our study, we do not advocate a single measure be strictly
mployed in clinical practice. Certainly, for some patients, follow-
ng changes in various anthropometric measures may prove clini-
ally useful in encouraging healthy weight goals. Many patients,
owever, will strive for better health through weight reduction. For
hese individuals, success is defined by a lower BMI, and not by
ther measures.
Rebecca P. Gelber, MD, DrPH
. Michael Gaziano, MD, MPH
. John Orav, PhD
oAnn E. Manson, MD, DrPH
ulie E. Buring, ScD
obias Kurth, MD, ScD
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eply
rs. Green and Lesser each raise several legitimate and thought-
rovoking issues regarding the article by Gelber et al. (1) and my
ccompanying editorial (2). Their letters highlight several of the
ore important challenges that we face in confronting the obesity
pidemic—first and foremost among these is the very problem of
efining obesity. I concur that there is no single measure of
diposity that is simple to obtain, highly reproducible, widely
vailable, and fully reflective of cardiovascular (or other) risk.
iven this problem, I tried to make a case in the editorial that for
majority of the population, particularly those in the age range
here interventions intended to induce loss of fat are most likely to
e beneficial (younger and middle-age patients), body mass index
BMI) performs nearly as well as waist circumference (or waist/hip
r waist/height). Therefore, until we find a better measure of
atness, I opined that we should continue to use BMI. All that
eing said, I readily agree that BMI has significant limitations as
means to define and quantify obesity.
Dr. Green correctly points out the irresolvable problem of
elating population statistics to the care of individual patients.
hile I agree fully with this point, I believe that the dilemma is
